Simmons Chia-Lin — SEC Form 4 filings
SEC reporting owner CIK 1868194. 10 Form 4 filings on record with FilingPulse; latest filed 2025-11-05.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-04-05 to 2025-11-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LogicMark, Inc. (LGMK) | President and CEO, Director | 8 | — | — | 13 |
| Channel Therapeutics Corp (CHRO) | Director | 2 | — | — | 2 |
Form 4 filings — Simmons Chia-Lin
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-11-05 | 4 | LogicMark, Inc. (LGMK) | Grant/award (A): 74,800 @ $0 | EDGAR |
| 2025-04-15 | 4 | Channel Therapeutics Corp (CHRO) | Grant/award (A): 25,000 (derivative) | EDGAR |
| 2025-03-31 | 4 | LogicMark, Inc. (LGMK) | Grant/award (A): 67,794 (derivative) @ $0.12 | EDGAR |
| 2025-02-20 | 4 | LogicMark, Inc. (LGMK) | Grant/award (A): 11,238 (derivative) @ $0.12 | EDGAR |
| 2025-01-06 | 4 | LogicMark, Inc. (LGMK) | Grant/award (A): 116,900 @ $0 | EDGAR |
| 2024-11-29 | 4 | LogicMark, Inc. (LGMK) | Grant/award (A): 4,851 (derivative) @ $0.12 · Grant/award (A): 4,851 (derivative) @ $0.12 | EDGAR |
| 2024-10-03 | 4/A | LogicMark, Inc. (LGMK) | Grant/award (A): 21,486 @ $0.46 · Grant/award (A): 62,772 (derivative) @ $0.01 · Grant/award (A): 21,486 (derivative) @ $0.01 | EDGAR |
| 2024-08-06 | 4 | LogicMark, Inc. (LGMK) | Grant/award (A): 21,486 @ $0.46 · Grant/award (A): 21,486 (derivative) @ $0.01 · Grant/award (A): 21,486 (derivative) @ $0.01 | EDGAR |
| 2024-06-18 | 4 | Chromocell Therapeutics Corp (CHRO) | Grant/award (A): 90,000 (derivative) | EDGAR |
| 2024-04-05 | 4 | LogicMark, Inc. (LGMK) | Grant/award (A): 46,200 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1868194 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →